Planning and Evaluation Core

规划与评估核心

• 批准号: 8136507
• 负责人: Gabriel Lopez-Berestein
• 金额: $ 7.04万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8136507
• 关键词: Applications Grants; Area; Basic Science; Cancer Center; Clinical; Clinical Cancer Center; Clinical Research; Clinical Trials; Collaborations; Commit; Communities; Community Clinical Oncology Program; Development; Diagnostic; Doctor of Philosophy; Effectiveness; Ensure; Evaluation; Faculty; Fostering; Funding; Goals; Grant; Hospitals; Information Dissemination; Inpatients; Island; Link; Malignant Neoplasms; Manuscripts; Mission; Monitor; National Cancer Program; Outpatients; Patients; Personnel Recruitments; Pharmacologic Substance; Phase; Phase II Clinical Trials; Phase III Clinical Trials; Population; Process; Puerto Rico; Recruitment Activity; Research; Research Activity; Research Infrastructure; Research Personnel; Research Project Grants; Structure; Students; System; Tissues; Training; Training Programs; Training and Education; Translational Research; United States National Institutes of Health; University of Texas M D Anderson Cancer Center; Update; Visit; Work; anticancer research; cancer health disparity; interest; member; outreach; outreach program; programs; symposium; treatment center; tumor registry; virtual; web site

To sustain the high quality of research expected from this Partnership, strict planning and evaluation processes have been implemented to monitor collaboration building, as well as all projects, programs and cores against both the Partnership's mission, goals and objectives, and the mission, goals and objectives of the U54 mechanism itself, It is our intent to utilize Partnership funding for projects and programs to nurture their development, but not to provide long-term support. As a part of building and sustaining excellence, all projects and programs undergo a strenuous review by our internal and external committees (Table 38) and are expected to (and must develop a plan to) apply for external funding from the NIH or an equivalent agency. These planning and evaluation processes are also instrumental in accurately assessing the Partnership's effectiveness towards achieving its immediate (1-3 years) and intermediate (4-5 years) goals (See Section 1.5) of establishing a sustainable research infrastructure (e.g., key personnel recruitment, clinical accrual cores, tissue cores, assigned building space, and further defining programmatic approaches toward the development of the roadmap to obtain cancer center designation) at the UPRCCC. Not to mention, strategically, a strong ¿ planning and evaluation process is needed to aid the Partnership in achieving its long-term goal (post-U54 funding) of regaining NCI-designation for the UPRCCC. Although regaining NCI-designation is not a direct goal within the scope of the U54 mechanism, as Pis, we believe that it is imperative for us to not just think in terms of U54 specifics, but to pursue goals beyond the U54. For us, regaining NCI-designation is a positive step towards building a stronger national cancer program aimed at understanding the reasons behind cancer health disparities and their impact on the populations we serve.

为了维持这种合作伙伴关系的高质量研究，严格的计划和评估流程 已实施以监视协作建设以及所有项目，计划和核心 伙伴关系的使命，目标和目标以及U54的使命，目标和目标 机制本身，我们的意图是利用合伙资金来进行项目和计划来护理他们的 发展，但不提供长期支持。作为建立和维持卓越的一部分，所有项目 并且计划接受了我们的内部和外部委员会的强烈审查（表38），并且是 期望（并且必须制定计划）申请NIH或同等机构的外部资金。 这些计划和评估过程也有助于准确评估合作伙伴关系 实现其立即（1 - 3年）和中级（4 - 5年）目标的有效性（请参阅第1.5节） 建立可持续研究基础设施（例如，关键人员招聘，临床核心， 组织内核，分配建筑空间，并进一步定义开发的程序化方法 在UPRCCC的路线图以获取癌症中心的名称）。更不用说，从战略上讲是一个强大的 需要计划和评估过程来帮助实现其长期目标（U54后） 为UPRCCC重新获得NCI设计的资金。尽管重新恢复NCI设计不是直接的 在U54机制范围内的目标，作为PI，我们认为我们不仅必须仅仅 根据U54的细节来考虑，但要追求U54以外的目标。对我们来说，重新设计了NCI设计 是迈向建立更强大的国家癌症计划的积极一步，旨在了解 癌症健康差异的原因及其对我们服务人群的影响。